chr19-47407517-G-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_020160.3(MEIS3):āc.908C>Gā(p.Ser303Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000311 in 1,608,000 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/17 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_020160.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MEIS3 | NM_001301059.2 | c.859-89C>G | intron_variant | ENST00000558555.6 | NP_001287988.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MEIS3 | ENST00000558555.6 | c.859-89C>G | intron_variant | 5 | NM_001301059.2 | ENSP00000454073.1 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152212Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000126 AC: 3AN: 238866Hom.: 0 AF XY: 0.0000153 AC XY: 2AN XY: 130538
GnomAD4 exome AF: 0.00000137 AC: 2AN: 1455788Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 724096
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152212Hom.: 0 Cov.: 31 AF XY: 0.0000269 AC XY: 2AN XY: 74366
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 18, 2023 | The c.908C>G (p.S303C) alteration is located in exon 9 (coding exon 9) of the MEIS3 gene. This alteration results from a C to G substitution at nucleotide position 908, causing the serine (S) at amino acid position 303 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at